Table 1 Characteristics of 113 patients treated with TPFa induction chemotherapy for locally advanced head and neck cancer
Male sex – no. (%) | 89 (79) |
Average age [min-max] (years) | 58 [32–71] |
WHO Performance Index – no. (%) | |
0 | 56 (50) |
1 | 52 (46) |
2 | 5 (4) |
Alcohol and tobacco use – no. (%) | |
Alcohol and tobacco use | 79 (70) |
Tobacco | 19 (17) |
Alcohol | 4 (3) |
No alcohol and tobacco use | 11 (10) |
Comorbidities – no. (%) | |
Hepatic dysfunction | 6 (5) |
Hepatic dysmorphia | 10 (13) |
Diabetes | 9 (8) |
High blood pressure | 17 (15) |
Ischemic heart disease | 2 (2) |
Obliterative arteriopathy of the lower limbs | 5 (4) |
Obstructive pulmonary disease | 8 (7) |
Stroke | 2 (2) |
Weight loss – median [min-max] (Kg) | −4,1[−28–7,81] |
Serum Albumin – median [IC-95%] (g/l) | 39,6 [37,6-39,8] |
Oral feeding possible at diagnosis – no. (%) | |
Yes | 88 (78) |
No | 25 (22) |
Enteral nutrition during TPF – no. (%) | |
Yes | 34 (30) |
No | 79 (70) |